MNTC Mentice AB (publ)

1.619USD16.45 SEK · STO-2.95%Mkt Cap: 45.54M USDP/E: —

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, a…

Key Statistics

Company
Market Cap45.54M USD
Enterprise Value41.11M USD
Revenue (TTM)30.04M USD
Gross Profit24.69M USD
Net Income (TTM)-3.18M USD
Revenue/Share1.07 USD
Last Price1.619 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees111
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0012673291
Valuation
P/E (Trailing)—
P/E (Forward)23.84
PEG—
EV/EBITDA-20.65
EV/Revenue1.37
P/S1.52
P/B4.18
EPS (TTM)-0.06 USD
EPS (Forward)0.07 USD
52W Range
1.18164% of range1.865
52W High1.865 USD
52W Low1.181 USD
Profitability
Gross Margin89.89%
Oper. Margin-7.22%
EBITDA Margin-6.63%
Profit Margin-11.59%
ROE-23.37%
ROA-10.36%
ROIC-25.80%
ROCE-21.28%
Growth
Revenue Growth2.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.00M USD
CapEx (TTM)1.52M USD
FCF Margin7.18%
FCF Yield4.74%
Net Debt-4.43M USD
Net Debt/EBITDA2.22
Net Debt/FCF-2.05
Balance Sheet
Debt/Equity0.12
Current Ratio0.94
Quick Ratio0.75
Book Value/Sh0.39 USD
Cash/Share0.21 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.264 USD
Upside (mean)+39.8%
Target Range1.575 USD – 2.953 USD
1.575+39.8% to mean2.953
# Analysts2
Ownership
Shares Out.28.13M
Float4.50M
Insiders71.98%
Institutions10.58%
Technical
SMA 501.494 (+8.4%)
SMA 2001.378 (+17.5%)
Beta0.50
S&P 52W Chg12.00%
Avg Vol (30d)16.83K
Avg Vol (10d)19.97K
Technical Indicators
RSI (14)55.9
MACD0.3345
MACD Signal0.2124
MACD Hist.+0.1221
BB Upper1.700 USD
BB Middle1.551 USD
BB Lower1.401 USD
BB Width19.30%
ATR (14)0.0758 USD
Vol Ratio (20d)0.48x

About Mentice (STO: MNTC)

›

Mentice (STO: MNTC) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 111 employees.

The shares were at 16.45 SEK on 19 November 2026, up 30.0% over 52 weeks. Its 52-week range is 12.00 SEK to 18.95 SEK: the price is 13.2% below the high and 37.1% above the low.

Its market capitalisation is 462.67M SEK.

Mentice reports return on equity of -23.4%, an operating margin of -7.2% and revenue up 2.9% year over year.

It holds more cash than debt, a net cash position of 45.00M SEK. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 2 analysts cover the stock, with an average rating of Buy; their mean price target of 23.00 SEK is 39.8% above the current price.